Document Detail

Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes.
MedLine Citation:
PMID:  20651469     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Patients with Prader-Willi syndrome (PWS) due to maternal uniparental disomy of the chromosome 15 (UPD15) have fewer facial features, less hypopigmentation and higher levels of psychosis compared to subjects with deletion in chromosome 15 (del15q11-q13). PWS individuals carrying the larger type I (TI) deletion suffer from greater behavioral problems than patients with the smaller type II (TII) deletion. Few data are currently available on the relationship existing between endocrine abnormalities in PWS subjects and the different genotypes.
AIM: To investigate the stimulated GH levels in PWS patients with different types of deletion and those with UPD15.
SUBJECTS AND METHODS: Thirty-seven patients, 14 males, aged 17.5-41.2 yr, with PWS due to TI deletion (no.=6), TII deletion (no.=15) or UPD15 (no.=16), were studied. Pituitary GH secretion was evaluated by dynamic testing with GHRH+arginine.
RESULTS: Both the mean peak GH response and the integrated GH secretion (GH area under the curve and GH area under the curve corrected for basal values) for the UPD15 patients (4.6±1.6 μg/l, 241.6±71.7 μg/l/h and 228.3±71.6 μg/l/h, respectively) were lower than that observed in all subjects with del15q11-q13 (9.1±1.8 μg/l, 547.0±132.3 μg/l/h and 514.9±127.6 μg/l/h: p<0.005), as well as in TI (7.7±1.2 μg/l: p<0.02; 424.2±88.8 and 393.4±88.8 μg/l/h: p<0.05) and TII (9.6±2.6 μg/l, 587.9±174.2 μg/l/h and 555.4±167.6 μg/l/h: p<0.01) deletion groups. TI and TII groups had similar stimulated GH levels and integrated GH secretion.
CONCLUSIONS: Our results point at differentiating the pattern of GH secretion by genetic subtypes, with higher GH responses in typical deletion subjects when compared to patients with UPD15.
G Grugni; D Giardino; A Crinò; F Malvestiti; L Ballarati; G Di Giorgio; P Marzullo
Related Documents :
9137979 - Reproducibility of growth hormone and cortisol responses to the insulin tolerance test ...
2080419 - Growth hormone (gh) release by arginin-vasotocin (avt) given intranasally in sexually i...
1464649 - The role of body mass in the response to growth hormone therapy.
23531429 - Effects of serum testosterone levels after 6 months of androgen deprivation therapy on ...
3558729 - Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedi...
11254469 - Cortisol and gh secretory dynamics, and their interrelationships, in healthy aged women...
7406279 - Longitudinal study of phenobarbital in serum, cerebrospinal fluid, and saliva in the dog.
7198689 - The pituitary-ovarian complex in the aged anoestrous golden hamster.
23023369 - Rivaroxaban delivery and reversal at a venous flow rate.
Publication Detail:
Type:  Journal Article     Date:  2010-07-22
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  34     ISSN:  1720-8386     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:    2011 Jul-Aug
Date Detail:
Created Date:  2011-09-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  493-7     Citation Subset:  IM    
Division of Auxology, S. Giuseppe Hospital, Research Institute, Istituto Auxologico Italiano, Verbania, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among met...
Next Document:  Adiponectin expression and metabolic markers in obesity and Type 2 diabetes.